Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure

dc.contributor.authorKonings GF
dc.contributor.authorSaarinen N
dc.contributor.authorDelvoux B
dc.contributor.authorKooreman L
dc.contributor.authorKoskimies P
dc.contributor.authorKrakstad C
dc.contributor.authorFasmer KE
dc.contributor.authorHaldorsen IS
dc.contributor.authorZaffagnini A
dc.contributor.authorHäkkinen MR
dc.contributor.authorAuriola S
dc.contributor.authorDubois L
dc.contributor.authorLieuwes N
dc.contributor.authorVerhaegen F
dc.contributor.authorSchyns LE
dc.contributor.authorKruitwagen RF
dc.contributor.authorENITEC Consortium
dc.contributor.authorXanthoulea S
dc.contributor.authorRomano A.
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id37484763
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/37484763
dc.date.accessioned2022-10-28T14:31:59Z
dc.date.available2022-10-28T14:31:59Z
dc.description.abstract<p>Endometrial cancer (EC) is the most common gynaecological malignancy in Western society and the majority of cases are estrogen dependent. While endocrine drugs proved to be of insufficient therapeutic value in the past, recent clinical research shows promising results by using combinational regimens and pre-clinical studies and identified potential novel endocrine targets. Relevant pre-clinical models can accelerate research in this area. In the present study we describe an orthotopic and estrogen dependent xenograft mouse model of EC. Tumours were induced in one uterine horn of female athymic nude mice using the well-differentiated human endometrial adenocarcinoma Ishikawa cell line—modified to express the luciferase gene for bioluminescence imaging (BLI). BLI and contrast-enhanced computed-tomograph (CE-CT) were used to measure non-invasive tumour growth. Controlled estrogen exposure was achieved by the use of MedRod implants releasing 1.5 μg/d of 17β-estradiol (E2) in ovariectomized mice. Stable E2 serum concentration was demonstrated by LC-MS/MS. Induced tumours were E2 responsive as increased tumour growth was observed in the presence of E2 but not placebo, assessed by BLI, CE-CT, and tumour weight at sacrifice. Metastatic spread was assessed macroscopically by BLI and histology and was seen in the peritoneal cavity, in the lymphovascular space, and in the thoracic cavity. In conclusion, we developed an orthotopic xenograft mouse model of EC that exhibits the most relevant features of human disease, regarding metastatic spread and estrogen dependency. This model offers an easy to manipulate estrogen dosage (by simply adjusting the MedRod implant length), image-guided monitoring of tumour growth, and objectively measurable endpoints (including tumour weight). This is an excellent in vivo tool to further explore endocrine drug regimens and novel endocrine drug targets for EC<br /></p>
dc.identifier.jour-issn1661-6596
dc.identifier.olddbid188819
dc.identifier.oldhandle10024/171913
dc.identifier.urihttps://www.utupub.fi/handle/11111/56032
dc.identifier.urnURN:NBN:fi-fe2021042720626
dc.language.isoen
dc.okm.affiliatedauthorSaarinen-Aaltonen, Niina
dc.okm.discipline1182 Biochemistry, cell and molecular biologyen_GB
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline1182 Biokemia, solu- ja molekyylibiologiafi_FI
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.relation.articlenumberE2547
dc.relation.doi10.3390/ijms19092547
dc.relation.ispartofjournalInternational Journal of Molecular Sciences
dc.relation.issue9
dc.relation.volume19
dc.source.identifierhttps://www.utupub.fi/handle/10024/171913
dc.titleDevelopment of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure
dc.year.issued2018

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
ijms-19-02547.pdf
Size:
6.21 MB
Format:
Adobe Portable Document Format
Description:
Publisher's version